428 related articles for article (PubMed ID: 20977108)
1. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
2. Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
Dwyre DM; Dursteler B; Nashelsky M; Friedman KD; Raife TJ
J Clin Apher; 2009; 24(3):106-10. PubMed ID: 19253359
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT; Cheves T; Sweeney JD
Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
[TBL] [Abstract][Full Text] [Related]
5. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.
van der Veen BS; Besseling R; Hoogendoorn M
Transfusion; 2015 Oct; 55(10):2511-5. PubMed ID: 26308736
[TBL] [Abstract][Full Text] [Related]
6. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
Bentley MJ; Wilson AR; Rodgers GM
Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.
Wu N; Liu J; Yang S; Kellett ET; Cataland SR; Li H; Wu HM
Transfusion; 2015 Jan; 55(1):18-24. PubMed ID: 24953079
[TBL] [Abstract][Full Text] [Related]
8. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
9. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange.
Bentley MJ; Lehman CM; Blaylock RC; Wilson AR; Rodgers GM
Transfusion; 2010 Aug; 50(8):1654-64. PubMed ID: 20412532
[TBL] [Abstract][Full Text] [Related]
10. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
[TBL] [Abstract][Full Text] [Related]
11. Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Expert Opin Pharmacother; 2007 Mar; 8(4):437-44. PubMed ID: 17309338
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Sadler JE
Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
[TBL] [Abstract][Full Text] [Related]
13. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
15. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
[TBL] [Abstract][Full Text] [Related]
16. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura in children.
Loirat C; Coppo P; Veyradier A
Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
[TBL] [Abstract][Full Text] [Related]
18. Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.
Barrows BD; Teruya J
Arch Pathol Lab Med; 2014 Apr; 138(4):546-9. PubMed ID: 24678685
[TBL] [Abstract][Full Text] [Related]
19. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy associated thrombotic thrombocytopenic purpura: Practical issues for patient management.
Savignano C; Rinaldi C; De Angelis V
Transfus Apher Sci; 2015 Dec; 53(3):262-8. PubMed ID: 26626962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]